1 |
Rohn H, Schramm S, Pansikaki K, Jansen S, Hendriks C, Platte M, Konik MJ, Dolff S, Wilde B, Kordelas L, Trilling M, Krawczyk A, Horn PA, Witzke O, Rebmann V. Peripheral HLA-G/ILT-2 immune checkpoint axis in acute and convalescent COVID-19 patients. Hum Immunol 2023:S0198-8859(23)00043-5. [PMID: 36925435 DOI: 10.1016/j.humimm.2023.03.002] [Reference Citation Analysis]
|
2 |
Siemaszko J, Marzec-Przyszlak A, Bogunia-Kubik K. Activating NKG2C Receptor: Functional Characteristics and Current Strategies in Clinical Applications. Arch Immunol Ther Exp (Warsz) 2023;71:9. [PMID: 36899273 DOI: 10.1007/s00005-023-00674-z] [Reference Citation Analysis]
|
3 |
Hamed RM, Mahmood MM, Ad'hiah AH. Evaluation of serum soluble HLA-G levels post-recovery from COVID-19 and post-vaccination (Sinopharm and Pfizer-BioNTech). Hum Immunol 2023;84:71-4. [PMID: 36369216 DOI: 10.1016/j.humimm.2022.11.002] [Reference Citation Analysis]
|
4 |
Srivastava A, Hollenbach JA. The immunogenetics of COVID-19. Immunogenetics 2022;:1-12. [PMID: 36534127 DOI: 10.1007/s00251-022-01284-3] [Reference Citation Analysis]
|
5 |
Ad'hiah AH, Al-bayatee NT. HLA-G 14-bp insertion/deletion polymorphism and risk of coronavirus disease 2019 (COVID-19) among Iraqi patients. Human Immunology 2022. [DOI: 10.1016/j.humimm.2022.03.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|